EVH
What one share of Evolent Health holds
Services – Management Services
Evolent is a market leader in connecting care for people with complex conditions like cancer, cardiovascular disease, and musculoskeletal diagnoses. We work on behalf of health plans and other risk-bearing entities and payers (our customers) to support physicians and other healthcare providers (our users) in providing high quality evidence-based care to their patients.
Evolent Health’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $18.64 |
|---|---|
| Profit | −$4.54 |
| Cash and investments | $1.02 |
| Debt | $8.55 |
| Book value | $3.39 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2016 | $5.64 | −$3.55 | $0.34 | −$1.13 | — | $15.60 |
| 2017 | $6.76 | −$0.94 | $0.43 | −$0.87 | — | $15.71 |
| 2018 | $8.11 | −$0.68 | $0.51 | −$0.78 | — | $14.79 |
| 2019 | $8.34 | −$3.67 | $0.43 | −$0.95 | — | $10.98 |
| 2020 | $10.89 | −$3.94 | — | −$0.19 | — | $7.20 |
| 2021 | $10.55 | −$0.44 | — | $0.45 | — | $7.64 |
| 2022 | $14.43 | −$0.20 | — | −$0.12 | — | $7.74 |
| 2023 | $17.65 | −$1.28 | — | $1.28 | — | $9.25 |
| 2024 | $22.28 | −$0.81 | — | $0.16 | — | $8.59 |
| 2025 | $16.43 | −$5.07 | — | $0.34 | — | $3.72 |